Dihydroartemisinin alleviates doxorubicin‐induced cardiotoxicity and ferroptosis by activating Nrf2 and regulating autophagy
The FASEB Journal · 31.05.2024 · 38 (10)
DOI: 10.1096/fj.202400222rr ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, online erschienen am 22.05.2024. Verfasst von Zhi-Hui Lin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, The Second Affiliated Hospital and Yuying Children's Hospital, Wenzhou Medical University, Wenzhou, China. Hauptthemen laut MEDLINE: Artemisinins, NF-E2-Related Factor 2, Autophagy, Doxorubicin. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Zhejiang Provincial Natural Science Foundation of China, Wenzhou Science and Technology Bureau, Wenzhou Municipal Science and Technology Bureau.
Abstract (Originalsprache)
Although the use of Doxorubicin (Dox) is extensive in the treatment of malignant tumor, the toxic effects of Dox on the heart can cause myocardial injury. Therefore, it is necessary to find an alternative drug to alleviate the Dox‐induced cardiotoxicity. Dihydroartemisinin (DHA) is a semisynthetic derivative of artemisinin, which is an active ingredient of Artemisia annua. The study investigates the effects of DHA on doxorubicin‐induced cardiotoxicity and ferroptosis, which are related to the activation of Nrf2 and the regulation of autophagy. Different concentrations of DHA were administered by gavage for 4 weeks in mice. H9c2 cells were pretreated with different concentrations of DHA for 24 h in vitro. The mechanism of DHA treatment was explored through echocardiography, biochemical analysis, real‐time quantitative PCR, western blotting analysis, ROS/DHE staining, immunohistochemistry, and immunofluorescence. In vivo, DHA markedly relieved Dox‐induced cardiac dysfunction, attenuated oxidative stress, alleviated cardiomyocyte ferroptosis, activated Nrf2, promoted autophagy, and improved the function of lysosomes. In vitro, DHA attenuated oxidative stress and cardiomyocyte ferroptosis, activated Nrf2, promoted clearance of autophagosomes, and reduced lysosomal destruction. The changes of ferroptosis and Nrf2 depend on selective degradation of keap1 and recovery of lysosome. We found for the first time that DHA could protect the heart from the toxic effects of Dox‐induced cardiotoxicity. In addition, DHA significantly alleviates Dox‐induced ferroptosis through the clearance of autophagosomes, including the selective degradation of keap1 and the recovery of lysosomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, The Second Affiliated Hospital and Yuying Children's Hospital, Wenzhou Medical University, Wenzhou, China.
- Intensive Care Unit, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
ORCID-Profile: Zhi-Hui Lin, Hua-Qiang Xiang, Yong-Wei Yu, Yang-Jing Xue, Chang Wu, Cong Lin, Kang-Ting Ji
Förderung
- Zhejiang Provincial Natural Science Foundation of China
- Wenzhou Science and Technology Bureau
- Wenzhou Municipal Science and Technology Bureau
Zitieren
APA
Lin, Z. H., Xiang, H. Q., Yu, Y. W., Xue, Y. J., Wu, C., Lin, C., & Ji, K. T. (2024). Dihydroartemisinin alleviates doxorubicin‐induced cardiotoxicity and ferroptosis by activating Nrf2 and regulating autophagy. The FASEB Journal, 38(10). https://doi.org/10.1096/fj.202400222rr
Vancouver
Lin ZH, Xiang HQ, Yu YW, Xue YJ, Wu C, Lin C, et al. Dihydroartemisinin alleviates doxorubicin‐induced cardiotoxicity and ferroptosis by activating Nrf2 and regulating autophagy. The FASEB Journal. 2024;38(10). doi:10.1096/fj.202400222rr
BibTeX
@article{Lin2024,
author = {Lin, Zhi-Hui and Xiang, Hua-Qiang and Yu, Yong-Wei and Xue, Yang-Jing and Wu, Chang and Lin, Cong and Ji, Kang-Ting},
title = {Dihydroartemisinin alleviates doxorubicin‐induced cardiotoxicity and ferroptosis by activating Nrf2 and regulating autophagy},
journal = {The FASEB Journal},
year = {2024},
volume = {38},
number = {10},
doi = {10.1096/fj.202400222rr}
}
EUVIMED